Passage Bio, Inc. (PASG) NASDAQ
5.90
+0.045(+0.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.90
+0.045(+0.77%)
Currency In USD
| Market Cap | 37.44M |
| Enterprise Value | 15.15M |
| P/E Ratio | -0.5 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.03 |
| Return On Equity | -1.51 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -728,000 |
| EBITDA | -42.42M |
| Net Income | -45.52M |
| Diluted EPS | -14.35 |
| Total Cash | 33.34M |
| Total Cash/Share | 10.4 |
| Total Debt | 5.76M |
| Total Debt/Equity | 0.49 |
| Current Ratio | 1.73 |
| Book Value Per Share | 3.67 |
| 52-Week Change | -32.4 |
| 52-Week High | 20 |
| 52-Week Low | 3.94 |
| Moving Average 50 Days | 6.68 |
| Moving Average 200 Days | 8.52 |
| Average Volume | 79,600 |
| Shares Outstanding | 3.21M |
| % Held by Institutions | 56.1 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | July 14, 2025 |